Does UPADACITINIB Cause Transaminases increased? 35 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Transaminases increased have been filed in association with UPADACITINIB (Rinvoq). This represents 0.1% of all adverse event reports for UPADACITINIB.
35
Reports of Transaminases increased with UPADACITINIB
0.1%
of all UPADACITINIB reports
0
Deaths
11
Hospitalizations
How Dangerous Is Transaminases increased From UPADACITINIB?
Of the 35 reports, 11 (31.4%) required hospitalization, and 7 (20.0%) were considered life-threatening.
Is Transaminases increased Listed in the Official Label?
Yes, Transaminases increased is listed as a known adverse reaction in the official FDA drug label for UPADACITINIB.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Transaminases increased?
METHOTREXATE (1,236)
ACETAMINOPHEN (929)
ATORVASTATIN (472)
RITUXIMAB (448)
CYCLOPHOSPHAMIDE (401)
PREDNISONE (362)
ADALIMUMAB (340)
PACLITAXEL (333)
ROSUVASTATIN (324)
CARBOPLATIN (319)
Which UPADACITINIB Alternatives Have Lower Transaminases increased Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL